Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

RMD

ResMed (RMD)

ResMed Inc
일자:
정렬 기준:
 검색 관련기사 보기:NYSE:RMD
일자시간출처헤드라인심볼기업
2024/05/1705:35GlobeNewswire Inc.ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP TherapyNYSE:RMDResMed Inc
2024/05/1621:05GlobeNewswire Inc.MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Data AccessNYSE:RMDResMed Inc
2024/05/1523:58Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:RMDResMed Inc
2024/05/0805:05GlobeNewswire Inc.ResMed Announces Participation in the RBCCM Global Healthcare ConferenceNYSE:RMDResMed Inc
2024/04/2605:05GlobeNewswire Inc.ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024NYSE:RMDResMed Inc
2024/04/0505:05GlobeNewswire Inc.ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024NYSE:RMDResMed Inc
2024/03/1516:05GlobeNewswire Inc.ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep CrisisNYSE:RMDResMed Inc
2024/03/0710:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:RMDResMed Inc
2024/03/0623:05GlobeNewswire Inc.Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP MaskNYSE:RMDResMed Inc
2024/03/0509:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:RMDResMed Inc
2024/03/0507:55Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:RMDResMed Inc
2024/03/0207:08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:RMDResMed Inc
2024/02/2408:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:RMDResMed Inc
2024/02/2311:41Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:RMDResMed Inc
2024/02/1306:16GlobeNewswire Inc.ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep ApneaNYSE:RMDResMed Inc
2024/02/0722:05GlobeNewswire Inc.MatrixCare Earns Three 2024 Best in KLAS AwardsNYSE:RMDResMed Inc
2024/02/0701:21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:RMDResMed Inc
2024/01/2920:09IH Market NewsPhilips Shares Drop 6% as US Sales Halted Following Agreement on Faulty Sleep Apnea Devices, and latest newsNYSE:RMDResMed Inc
2024/01/2920:09IH Market NewsPhilips Shares Drop 6% as US Sales Halted Following Agreement on Faulty Sleep Apnea Devices, and more Wall Street HighlightsNYSE:RMDResMed Inc
2024/01/2603:48Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:RMDResMed Inc
2024/01/2506:06Edgar (US Regulatory)Form 8-K - Current reportNYSE:RMDResMed Inc
2024/01/2506:05GlobeNewswire Inc.ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024NYSE:RMDResMed Inc
2024/01/0406:05GlobeNewswire Inc.ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024NYSE:RMDResMed Inc
2024/01/0405:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:RMDResMed Inc
2023/12/2806:05GlobeNewswire Inc.ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare ConferenceNYSE:RMDResMed Inc
2023/12/2106:05GlobeNewswire Inc.ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical DevicesNYSE:RMDResMed Inc
2023/12/1206:05GlobeNewswire Inc.ResMed Secures Significant Victory in Patent Fight Against New York UniversityNYSE:RMDResMed Inc
2023/12/0805:34GlobeNewswire Inc.Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients GloballyNYSE:RMDResMed Inc
2023/11/3009:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:RMDResMed Inc
2023/11/2807:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:RMDResMed Inc
 검색 관련기사 보기:NYSE:RMD